Literature DB >> 10987652

Molecular genetics of human prion diseases in Germany.

O Windl1, A Giese, W Schulz-Schaeffer, I Zerr, K Skworc, S Arendt, C Oberdieck, M Bodemer, S Poser, H A Kretzschmar.   

Abstract

Human prion diseases may be acquired as infectious diseases, they may be inherited in an autosomal dominant fashion or occur sporadically. Mutations and polymorphisms in the sequence of the coding region of the prion protein gene (PRNP) have been established as an important factor in all of these three types of prion diseases. Therefore, a total of 578 patients with suspect prion diseases referred to the German Creutzfeldt-Jakob disease (CJD) surveillance unit over a period of 4.5 years have been examined for mutations and polymorphisms in the coding region of PRNP. We found 40 cases with a missense mutation previously reported as pathogenic. Amongst these, the aspartate to asparagine change at codon 178 (D178N) was the most common mutation. All of these cases carried the D178N mutation in coupling with methionine at codon 129, resulting in the typical fatal familial insomnia (FFI) genotype. Most cases with pathogenic mutations were not found in the group of clinically "probable" cases according to established clinical criteria, supporting the notion that inherited prion diseases often exhibit atypical features. Two novel missense mutations (T188R and P238S) and several silent polymorphisms were found, demonstrating the quality of our screening procedure based on a modified version of the single-stranded conformational polymorphism technique. In "definite" CJD cases with no pathogenic mutation, the patients clinically classified as "probable" were mostly homozygous for methionine at the common polymorphism at codon 129, whereas there was a marked over-representation of patients homozygous for valine amongst those clinically classified as "possible". This large study on suspect cases of human prion diseases in Germany clearly shows that PRNP genetics is essential for a comprehensive analysis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10987652     DOI: 10.1007/s004399900124

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  49 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Creutzfeldt-Jakob disease associated with an R148H mutation of the prion protein gene.

Authors:  Bjarne Krebs; Rosa-Maria Lederer; Otto Windl; Eva-Maria Grasbon-Frodl; Inga Zerr; Hans A Kretzschmar
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

3.  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

Authors:  G Gossrau; B Herting; S Möckel; A Kempe; R Koch; H Reichmann; J B Lampe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

4.  Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study.

Authors:  C Vollmert; O Windl; W Xiang; A Rosenberger; I Zerr; H-E Wichmann; H Bickeböller; T Illig; H A Kretzschmar
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

5.  Analysis of PRNP gene codon 129 polymorphism in the Greek population.

Authors:  Angelica A Saetta; Nikolaos V Michalopoulos; George Malamis; Polyanthi I Papanastasiou; Niki Mazmanian; Maria Karlou; Anastasios Kouzoupis; Penelope Korkolopoulou; Efstratios Patsouris
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

6.  Clinical findings and diagnosis in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Uta Heinemann; Claudia Ponto; Jasmine Kortt; Kai Kallenberg; Daniela Varges; Walter J Schulz-Schaeffer; Hans A Kretzschmar; Inga Zerr
Journal:  Eur J Epidemiol       Date:  2015-06-16       Impact factor: 8.082

7.  PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.

Authors:  Franc Llorens; Belén Ansoleaga; Paula Garcia-Esparcia; Saima Zafar; Oriol Grau-Rivera; Irene López-González; Rosi Blanco; Margarita Carmona; Jordi Yagüe; Carlos Nos; José Antonio Del Río; Ellen Gelpí; Inga Zerr; Isidre Ferrer
Journal:  Prion       Date:  2013-09-18       Impact factor: 3.931

Review 8.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

9.  Human Prion disease with a T188K mutation in Chinese: a case report.

Authors:  Qi Shi; Chen Gao; Wei Zhou; Bao-Yun Zhang; Chan Tian; Jian-Ming Chen; Hui-Ying Jiang; Jun Han; Xiao-Ping Dong
Journal:  Cases J       Date:  2009-05-29

10.  Ovine reference materials and assays for prion genetic testing.

Authors:  Michael P Heaton; Kreg A Leymaster; Theodore S Kalbfleisch; Brad A Freking; Timothy P L Smith; Michael L Clawson; William W Laegreid
Journal:  BMC Vet Res       Date:  2010-04-30       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.